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Background: Patients may acquire ventilator-associated pneumonia (VAP) by aspirating the condensate that
originates in the ventilator circuit upon use of a conventional humidifier. The bacteria that colonize the patients
themselves can proliferate in the condensate and then return to the airways and lungs when the patient aspirates
this contaminated material. Therefore, the use of HME might contribute to preventing pneumonia and lowering
the VAP incidence. The aim of this study was to evaluate how the use of HME impacts the probability of VAP
occurrence in critically ill patients.
Methods: On the basis of the acronym “PICO” (Patient, Intervention, Comparison, Outcome), the question that
guided this review was “Do critically ill patients under invasive mechanical ventilation present lower VAP incidence
when they use HME as compared with HH?”. Two of the authors of this review searched the databases PUBMED/
Medline, The Cochrane Library, and Latin-American and Caribbean Literature in Health Sciences, LILACS independently;
they used the following keywords: “heat and moisture exchanger”, AND “heated humidifier”, AND “ventilator-associated
pneumonia prevention”. This review included papers in the English language published from January 1990 to
December 2012.
Results: This review included ten studies. Comparison between the use of HME and HH did not reveal any differences
in terms of VAP occurrence (OR = 0.998; 95% CI: 0.778–1.281). Together, the ten studies corresponded to a total sample
of 1077 and 953 patients in the HME and HH groups, respectively; heterogeneity among the investigations was low
(I2 < 50%). Information about the outcome mortality was available in only eight of the ten studies. The use of HME and
HH did not afford different results in terms of mortality (OR = 1.09; 95% CI: 0.864–1.376). The total sample size was 884
and 762 patients, respectively. Heterogeneity among the studies was low (I2 = 0.0%).
Conclusion: Current meta-analysis was not sufficient to definitely exclude an associate between heat and moisture
exchangers and VAP. Despite the methodological limitations found in selected clinical trials, the current meta-analysis
suggests that HME does not decrease VAP incidence or mortality in critically ill patients.
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Nosocomial pneumonia remains to be one of the main
causes of infection in intensive care units (ICU) [1,2].
This condition is associated with the length of hospital
stay [1,3], duration of mechanical ventilation, and use of
broad-spectrum antibiotics. In the particular case of
Brazil, nosocomial pneumonia is the primary cause of
infection among critically ill patients admitted to the
ICU, which is associated with increased hospital costs
[1,2,4-6] and mortality [3,6]. This type of pneumonia occurs
more frequently in patients submitted to mechanical ven-
tilation for over 48 h, so it is commonly designated
ventilator-associated pneumonia (VAP) [7]. VAP diagnosis
relies on the emergence of a new pulmonary infiltrate or
the presence of progressive pulmonary filtrate accompanied
by fever, leukocytosis, and purulent secretion [7]. Mortality
due to VAP varies between 24 and 50% and may reach rates
as high as 76% in patients with comorbidities such as
COPD, diabetes and other chronic lung diseases [8].
Mechanical ventilation suppresses the natural mecha-
nisms that moisturize and heat inhaled air. When pa-
tients use an artificial airway, it is necessary to couple
the ventilation system with a device that compensates
for this suppression [9]. The lack of adequate moistu-
rizing may thicken the secretions, which augments re-
sistance to the passage of air, reduces the gas exchange
effectiveness, and increases the risk of respiratory infec-
tions [10]. Air moisturizing and heating can be achieved
actively (through the use of heated humidifiers, HH) or
passively (by means of heat and moisture exchangers,
HME) [1].
Patients may acquire VAP by aspirating the condensa-
tion of water (ie, overhumidification) that originates in
the ventilator circuit upon use of a conventional humidi-
fier. The bacteria that colonize the patients themselves
can proliferate in the condensate and then return to the
airways and lungs when the patient aspirates this con-
taminated material [10-12]. Therefore, the use of HME
might contribute to preventing pneumonia and lowering
the VAP incidence.
Many research papers have compared HME and HH in
terms of VAP occurrence [13-17]. However, data about how
effectively HME prevents VAP remain inconclusive. Hence,
this study aimed to evaluate how the use of HME impacts
the probability of VAP occurrence in critically ill patients.
Methods
Data sources and search strategies
This is a systematic review of the literature with meta-
analysis. The methodology involved six stages: selection
of the hypothesis, selection of the studies, definition of
the characteristics, analysis of the studies included in
this revision, interpretation of the results, and synthesis
of the results.On the basis of the acronym “PICO” (Patient, Interven-
tion, Comparison, Outcome), the question that guided this
review was “Do critically ill patients under invasive mech-
anical ventilation present lower VAP incidence when they
use HME as compared with HH?”. Two of the authors of
this review searched the databases PUBMED/Medline, The
Cochrane Library, and Latin-American and Caribbean
Literature in Health Sciences, LILACS independently;
they used the following keywords: “heat and moisture
exchanger”, AND “heated humidifier”, AND “ventilator-
associated pneumonia prevention”. Table 1 presents the
strategy these authors used to search for scientific evidence
in the databases. This review included papers in the English
language published from January 1990 to December 2012.Study selection
This review only considered controlled randomized clin-
ical assays that evaluated the use of HME as compared
with HH to prevent VAP in critically ill patients. Exclu-
sion criteria included: studies that did not associate the
use of exchanger with VAP, experimental (non-clinical)
studies, economic assessments and reviews, and articles
that were not fully available. The following information
was relevant for data collection: (1) paper identification
(paper and journal title, main author, year of publication,
and study locations); (2) assessment criteria used in the
studies (exchanger type); (3) methodological characteris-
tics [study type, study aims, results (impact of the ex-
changer on VAP prevention and possible complications),
limitations, and conclusions]. The final sample consisted
of 10 articles. Figure 1 illustrates the inclusion process.Data analysis and statistical methods
The model to assess the quality of clinical assays proposed
by the Oxford Centre for Evidence-based Medicine–Levels
of Evidence (2009) helped to evaluate the quality of the
evidence. Meta-analysis considered two outcomes, namely
VAP occurrence and mortality rate among patients be-
longing to the HME (Intervention A) and the HH (Inter-
vention B) groups, which meant that the outcomes were
dichotomous. Odds Ratio (OR) and its 95% Confidence
Interval (95% CI) were used for the results of each study
and for the synthesis. The Cochran’s Q and the I-square
(I2) tests aided evaluation of heterogeneity. All the data
were reported considering 95% CI and two-tailed p values.
The random effects model was employed in the case of
significant heterogeneity among the studies (I2 > 50). The
fixed effects model was applied for non-significant hete-
rogeneity (I2 < 50). The meta-analysis was graphically re-
presented by a Forest plot; the publication bias will be
represented by a funnel plot. The software Comprehensive
Meta Analysis™ version 2.2.064 (CMA Inc. USA) was
employed to analyze and record data.
Table 1 Search in electronic databases conducted on 01st December 2012
Electronic base Search strategy Studies





((“Heat and Moisture Exchanger” AND (“heated humidifier”) AND (“ventilator associated pneumonia” OR “ventilator
associated pneumonia prevention”))
50
(Selection criteria: review studies and clinical assays)
LILACS ((“Filtro Trocador de Calor e Umidade” E (Umidificador aquecido”) (“Pneumonia associada à Ventilação Mecânica” OU
“Prevenção de Pneumonia associada à Ventilação Mecânica”)). ((“Heat and Moisture Exchanger” AND (“heated humidifier”)
AND (“ventilator associated pneumonia” OR “ventilator associated pneumonia prevention”))
93
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This review included ten studies. Table 2 summarizes
the main results and depicts the characteristics of each
publication in detail, including the level of evidence pro-
vided by each study.
Table 3 compares the VAP incidence and mortality in
the different clinical assays.
Meta-analysis provided a synthesis of the results con-
sidering the VAP outcome in the ten clinical assays se-
lected for this review (Figure 2).Figure 1 Flow chart for the selection of studies included in this reviewComparison between the use of HME and HH, in this
meta-analysis did not reveal any differences in terms
of VAP occurrence (OR = 0.998; 95% CI: 0.778–1.281).
Together, the ten studies corresponded to a total sample
of 1077 and 953 patients in the HME and HH groups,
respectively; heterogeneity among the investigations was
low (I2 < 50%).
Information about the outcome mortality was available
in only eight of the ten studies. Hence, the results synthe-
sis can be seen in the referent meta-analysis (Figure 3)..
Table 2 Characterization of the studies on the use of heat and moisture exchangers as compared with the conventional humidifiers
Study/Country Setting Data analysis Study limitations Complications Other benefits Evidence level
Martin et al., 1990 [23] ICU Quantitative variables were
compared using the Student t
test.
Pneumonia was diagnosed on
the basis of purulent secretion. It
did not involve VAP incidence
density.
Hypothermia in 22% and 12% of
the patients belonging to the
HME and HH groups, respectively
(p < 0.01). Six and no cases of
tube occlusion were reported in
the HME and HH groups,
respectively (p < 0.01).
Not reported. 1C
The study was interrupted after
the death of a patient belonging
to the HME group due to total
obstruction of the endotracheal
tube.
Roustan et al., 1992 [26] ICU Both groups were compared
using the Student t, Mann–
Whitney, Chi-square, and Fisher
exact tests for differences in
frequency. Regression was
conducted for the incidence of
nosocomial pneumonia,
atelectasis, and tube occlusion.
Sample size was not calculated. Nine and no events of
endotracheal tube occlusion in
the HME and HH groups,
respectively. Nine and ten
episodes of atelectasis in the HH




Dreyfuss et al., 1995 [22] ICU The Student t test was used for
the continuous variables. The
Chi-square test with Yates
correction was employed for the
categorical variables. The Mann–




was not described. Various
patients were excluded after
randomization. Sample size
calculation was not reported.
Report of severe occlusion that
required cannula exchange due
to clotting (patients with
hematemesis) in the HME group.
Six patients required cannula
exchange due to obstruction by
secretion in the HME group.
The use of HME reduces costs
and staff working time.
1C
Boots et al., 1997 [21] ICU The patients’ characteristics were
compared by paired t test. The




Not reported. The use of HME reduces costs. 1C
Kirton et al., 1997 [24] ICU Analysis of variance and non-




The HME and HH groups did not
differ in terms of endotracheal
tube obstruction.
The use of HME reduces costs. 1C
Kollef et al., 1998 [25] ICU Student t and Wilcoxon tests
were used (according to normal
and non-normal distribution).
The randomization procedure
was not described. No mention
of blinded study.
Tube obstruction was not
detected in any of the groups.
The use of HME reduces costs by
50%.
1C
Chi-square and exact Fisher tests
were employed to compare
categorical variables.
Time elapsed during filter
exchange was not controlled.
Results were confirmed by
multiple logistic regressions.



















Table 2 Characterization of the studies on the use of heat and moisture exchangers as compared with the conventional humidifiers (Continued)
Memish et al., 2001 [20] ICU The Student t test was
employed.
The statistical power was not
calculated.
Not reported. Nursing staff spends less time
discarding the condensate that
builds up in the circuit. The use
of HME reduces costs.
1C
Lacherade et al., 2005 [14] ICU The Student t test was employed
for continuous variables. The Chi-
square test was used for the
categorical variables. Multivariate
logistic regression was also
performed.
Differences between the two
populations with respect to HIV
infection. Physicians and
researchers were not blinded.
Tube occlusion rates were lower
in the HME group (1 case) as
compared with the HH group
(5 cases).
On the basis of literature studies,
the paper mentions that the use
of HME reduces costs.
1C
Boots et al., 2006 [15] ICU Sample size was determined
using the difference between
two ratios. Univariate analysis
involved the use of Student t
and Kruskal-Wallis tests. The
difference in VAP rate among
groups was evaluated by Kaplan-
Meier and log rank tests.
Pneumonia was diagnosed
according to CPIS (Clinical
Pulmonary Infection Score).
HME may present higher
resistance to airflow than the
manufacturer’s specifications
after use for 24 h.
The use of HME reduces costs. 1C
Lorente et al., 2006 [19] ICU Quantitative variables were
compared using the Student t
test. Five risk models
proportional to Cox were
constructed for VAP analysis.
Temperature and moisture were
not monitored. VAP diagnosis
was confirmed by tracheal
aspirate. After randomization,
patients under mechanical
ventilation for less than five days
were excluded. Sample
calculation was conducted, but it
did not reach a sufficient
number of patients. Wide
confidence interval. Incidence
density was not approached.
Immunosuppressed patients
were excluded.
Not reported. No benefits have been reported
for the use of HME.
1C


















Table 3 Description of the participants, VAP incidence, and mortality in the selected clinical assays
Paper Sample size VAP incidence
(% or per 1000 mechanically ventilated patients/day)
p value Mortality (%) p value
HME group HH group HME group HH group HME group HH group
Martin et al.,
1990 [23]
31 patients under MV 42 patients under MV 7% 19% >0.05 22 26 >0.05
Roustan et al.,
1992 [26]

















140 patients under MV Early: 35 VAP cases per
one thousand ventilated
patients per day
Early: 31 VAP cases per
one thousand ventilated
patients per day
Early: p = >0.05
Data not shown
Late: < 0.05
Late: 12 VAP cases per
one thousand ventilated
patients per day







147 patients under MV 20 VAP cases per one
thousand ventilated
patients per day
27.6 VAP cases per
one thousand ventilated
patients per day







120 patients under MV 13.3 VAP cases per one
thousand ventilated
patients per day.
15.7 VAP cases per one
thousand ventilated
patients per day.





184 patients under MV 27.4 VAP cases per one
thousand ventilated
patients per day
25.3 VAP cases per one
thousand ventilated
patients per day






190 patients 2 HH groups 13% - Group with heating upon
inspiration: 10%
0.61 15 - Group with heating
upon inspiration: 14
> 0.05
- Group with heating upon
inspiration: 94
- Group with heating upon
inspiration and expiration: 97
- Group with heating upon
inspiration and expiration: 10%







51 patients under MV 21 episodes (39%) 8 episodes (15%) Hazard Ratio 16.2
(4.54-58.04) Data not shown
p < 0.05


















Figure 2 Synthesis of the results considering the VAP outcome in the ten clinical assays selected for this review.
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http://www.biomedcentral.com/1471-2253/14/115In this meta-analysis the use of HME and HH was not
associated with different rates/risk of mortality (OR = 1.09;
95% CI: 0.864–1.376). The total sample size was 884 and
762 patients, respectively. Heterogeneity among the stu-
dies was low (I2 = 0.0%).
Considering the two outcomes investigated here,
Figure 4 does not evidence any publication bias.
Discussion
Literature studies have presented conflicting results about
how HME impacts VAP prevention. A meta-analysis in-
cluding nine studies and 1368 patients revealed that HME
reduced VAP rates especially in the case of subjects submit-
ted to mechanical ventilation for over seven days (RR = 0.7;
IC 95%: 0.50-0.94). However, non-randomized studies (not
included in this meta-analysis) found significantly lower
VAP rates in the groups that used HH as compared with
HME [18]. Other two randomized studies reported non-
significantly different VAP rates for HH and HME [14,15].
A randomized study of 120 patients demonstrated smaller
VAP incidence during the use of HH in patients under
mechanical ventilation for periods longer than five days
(15.69 vs 39.62%, P = 0.006) [19]. A meta-analysis published
by Siempos et al. (2007) [16] included 13 randomized clin-
ical assays and 2,580 patients; it did not detect any dif-
ferences between HME and HH with respect to VAP
incidence, mortality in the ICU, length of stay in the ICU,
period of mechanical ventilation, or airway obstruction.Most studies have found similar VAP rates for HME
and HH [14-18,20-26]. In most of these studies, the
HME and HH groups did not differ in terms of VAP in-
cidence density, period of mechanical ventilation, length
of stay in the ICU, or global mortality rate.
Kirton et al. (1997) [24] evaluated 280 trauma patients
and demonstrated lower VAP incidence during the use of
HME. On the other hand, Auxiliadora-Martins et al. (2012)
[17] investigated severely ill patients (mean APACHE II
score > 25) with associated comorbidities, to find that the
HH and HME group did not have different VAP inci-
dence. The heterogeneous study populations, the distinct
brands of HME employed in the aforementioned studies,
the frequency with which the nursing staff changed the
moisturizer, and the criteria used to diagnose VAP may
have contributed to these contrasting results [19]. Never-
theless, HME did offer advantages over HH: it did not re-
quire that the staff opened the device circuit to remove
the condensate accumulated in the ventilator extensions,
which reduced the occupational risk and optimized the
work of the nursing team. In addition, it may have some
disadvantages using HH; such as high maintenance costs
and mechanical malfunction of the humidification and
mechanical ventilator apparatus, and overheating of the
inspired gases. These problems could be avoided by using
HME [10-12,17].
Even though many studies have shown that the use of
HME incurs lower costs [14,15,21,22,24,25], this device
Figure 3 Synthesis of the results considering mortality in eight of the ten studies. Meta-analysis containing Forest plot and Odds Ratio
values of each study and summarized Odds Ratio by the fixed effects model with their respective 95% CI; beyond the value of Q and I2 tests,
considering HME (A) and HH (B).
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most probable adverse effect, and its frequency is signifi-
cantly different in patients submitted to HME and HH
[14,22,23,26]. Lower moisture production may account
for this difference, especially during application of larger
minute volumes. This is a common event in all the
commercially available devices, albeit to different extent
[27-29]. Martin et al. (1990) [23] have also described
more frequent cases of hypothermia in patients using
HME. In contrast, Kirton et al. (1997) [24] and KollefFigure 4 Considering the two outcomes investigated here, there was
no evidence of publication bias on VAP (A) and mortality (B) outcomes.et al. (1998) [25] did not observe any differences between
the HH and HME groups in terms of tube occlusion. The
use of HME involves other concerns: increased dead vo-
lume due to hypercapnia and larger airway resistance,
which depend mainly on the filter internal volume and
liquid accumulation, respectively [29-31].
In most studies the change of HME was every 24 or
48 hours according manufacturer’s recommendation.
Other studies have demonstrated that prolonged use of
HME, from 24–48 h up to four or seven days, does notno evidence any publication bias. Funnel plot showing that there is
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http://www.biomedcentral.com/1471-2253/14/115incur increased risk of VAP [31-35]. Davis et al. did not
detect reduced efficiency, increased resistance, or altered
bacterial colonization when the use of HME was discon-
tinued after three days. The VAP incidence rate did not
change, either, so the authors concluded that the use of
HME for over 24 h, up to 72 h, is safe and economically
advantageous.
Together, the analyzed studies suggest that it is pos-
sible to use either HH or HME without significantly
impacting the VAP incidence. Considering hospital costs
and in the absence of contraindications, HME should
be employed as an alternative humidifier in patients
submitted to mechanical ventilation. The results of the
present review agree with the pathophysiology proposed
for VAP in the sense that bacteria inoculation into the
lungs generally occurs via extraluminal source, whereas
only occasionally does the intraluminal pathway happen.
Considering a 30% reduction in the occurrence of
VAP among patients who used respectively, HH (16%)
and HME (11%), with a significance level of 5% and a
statistical power of 80%, the minimum sample per group
would be 731 subjects. In the present meta-analysis, it
was evaluated studies with 953 subjects in the HH group
and 1077 in the HME group, thus this review presents a
sufficient sample size to detect this difference. However
there are some potential limitations should be consid-
ered. Firstly, the sample size was sufficient to detect a
30% reduction in VAP rates; the power of the study was
not sufficient to identify more modest reductions, al-
though smaller reductions could still be important from
a clinical perspective. Secondly, some studies were not
calculated sample size and were not described the ran-
domization procedure. Thirdly, in two studies patients
were excluded after randomization and other two studies
were non blinded. Finally, the definitions of VAP varied
in some included studies. Thus other double-blind stu-
dies, randomized controlled should be performed to def-
initely exclude an associate between heat and moisture
exchangers and VAP.
Hence, the studies included in this meta-analysis did
not attest that the use of HME in the ICU setting re-
duced the VAP incidence or affected mortality rates. On
the basis of these two outcomes (VAP incidence and
mortality), the meta-analysis of the selected studies was
reliable, given that the samples had low heterogeneity.
Conclusion
Current meta-analysis was not sufficient to definitely ex-
clude an associate between heat and moisture exchangers
and VAP. Despite the methodological limitations found in
selected clinical trials, the current meta-analysis suggests,
with some degree of uncertainty, that HME does not de-
crease VAP incidence or mortality in critically ill patients
and therefore, further clinical trials with greatermethodological rigor and adequate sample size should be
performed comparing HH to HME in the incidence of
VAP and other important outcomes such as mortality. Is
important to highlight that, institutions routinely using
HME should be aware of obstruction events and cases of
hypercapnia and hypothermia, because some studies have
described their occurrence.
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